Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frey

Showing results (281-290 of 368) with videos related to

Pageof 37
Sort By:
Plos One|February 15, 2013
Comparative genomics of 12 strains of Erwinia amylovora identifies a pan-genome with a large conserved coreRachel A Mann, Theo H M Smits, Andreas Bühlmann, et al.
Frontiers in Oncology|February 21, 2024
Immunotherapy utilization in stage IIIA melanoma: less may be moreAlexander E Frey, Daniel M Kerekes, Sajid A Khan, et al.
Clinical and Experimental Immunology|November 1, 1994
HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials NetworkG J Gorse, D H Schwartz, B S Graham, et al.
Vaccine|November 27, 2007
Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challengeSharon E Frey, Frances K Newman, Jeffrey S Kennedy, et al.
Journal of Bacteriology|March 1, 2012
Complete genome sequence of clinical isolate Pantoea ananatis LMG 5342Pieter De Maayer, Wai Yin Chan, Fabio Rezzonico, et al.
Vaccine|March 10, 1998
Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M J McElrath, T J Matthews, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2016
Transition guidelines: An important step in the future care for childhood cancer survivors. A comprehensive definition as groundworkR L Mulder, H J H van der Pal, G A Levitt, et al.
Vaccine|March 20, 2023
Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trialRobert L Atmar, David I Bernstein, Patricia Winokur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research NetworkRobert L Atmar, Getahun Abate, Meagan E Deming, et al.
Clinical & Translational Immunology|January 28, 2021
Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisationRosangela Salerno-Gonçalves, Wilbur H Chen, Mark J Mulligan, et al.
Pageof 37

Showing results (281-290 of 368) with videos related to

Sort By:
Pageof 37
Plos One|February 15, 2013
Comparative genomics of 12 strains of Erwinia amylovora identifies a pan-genome with a large conserved coreRachel A Mann, Theo H M Smits, Andreas Bühlmann, et al.
Frontiers in Oncology|February 21, 2024
Immunotherapy utilization in stage IIIA melanoma: less may be moreAlexander E Frey, Daniel M Kerekes, Sajid A Khan, et al.
Clinical and Experimental Immunology|November 1, 1994
HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials NetworkG J Gorse, D H Schwartz, B S Graham, et al.
Vaccine|November 27, 2007
Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challengeSharon E Frey, Frances K Newman, Jeffrey S Kennedy, et al.
Journal of Bacteriology|March 1, 2012
Complete genome sequence of clinical isolate Pantoea ananatis LMG 5342Pieter De Maayer, Wai Yin Chan, Fabio Rezzonico, et al.
Vaccine|March 10, 1998
Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, M J McElrath, T J Matthews, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2016
Transition guidelines: An important step in the future care for childhood cancer survivors. A comprehensive definition as groundworkR L Mulder, H J H van der Pal, G A Levitt, et al.
Vaccine|March 20, 2023
Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trialRobert L Atmar, David I Bernstein, Patricia Winokur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research NetworkRobert L Atmar, Getahun Abate, Meagan E Deming, et al.
Clinical & Translational Immunology|January 28, 2021
Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisationRosangela Salerno-Gonçalves, Wilbur H Chen, Mark J Mulligan, et al.
Pageof 37